Skip to content
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
align-justify
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
user-group
INVESTOR ACCESS
Search
Search
Close this search box.
apps
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
Home
/
Venture Capital
/
MRM Health Reports Preclinical...
Venture Capital
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
6 June 2022
Download
Press Release
Download
Related News
Venture Capital
Other news
September 10, 2024
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
arrow-up-right
Others
Other news
September 5, 2024
Jean-Guillaume LAFAY, Former CEO of Mablink, joins Mérieux Equity Partners Innovation Team as Operating Partner
arrow-up-right
Buyout
Buyout
July 3, 2024
Mérieux Equity Partners announces two promotions to strengthen its Buyout Team
arrow-up-right
